DJ Novavax Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 4.26% to $8.09 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 45,216.14 and the NASDAQ Composite Index falling 0.73% to 20,794.64.
This was the stock's third consecutive day of losses.
Novavax Inc. closed 32.41% short of its 52-week high of $11.97, which the company achieved on February 26th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.85% to $242.49, Pfizer Inc. $(PFE)$ rose 2.70% to $27.77, and Merck & Co. Inc. $(MRK)$ fell 1.28% to $118.10.
Trading volume (4.1 M) remained 1.1 million below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 30, 2026 17:28 ET (21:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments